About Pfênex, Inc.

Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

At the moment the company generates 32M USD in revenues.

On its last earning announcement, the company reported a loss of -0.46$ per share.

The book value per share is 1.76$

Pfênex, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
32M 84.50% -15M -48.20% -15M -0.46 - - 32M 1.76 -34M -2M -36M